Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris.

[1]  K. Thygesen,et al.  Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. , 1997, Circulation.

[2]  D. Ardissino,et al.  C-reactive protein elevation and early outcome in patients with unstable angina pectoris. , 1997, The American journal of cardiology.

[3]  Stgrp Capture,et al.  Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study , 1997, The Lancet.

[4]  A. Jaffe,et al.  Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. , 1997, Circulation.

[5]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[6]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[7]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[8]  L. Wallentin,et al.  Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. , 1996, Circulation.

[9]  P. Hansen,et al.  Role of neutrophils in myocardial ischemia and reperfusion. , 1995, Circulation.

[10]  A. Maseri,et al.  Relation of severity of symptoms to transient myocardial ischemia and prognosis in unstable angina. , 1995, Journal of the American College of Cardiology.

[11]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[12]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[13]  H. Weisman,et al.  Randomized Trial of a GPIIb/IIIa Platelet Receptor Blocker in Refractory Unstable Angina , 1994, Circulation.

[14]  M. Entman,et al.  Inflammation in Acute Coronary Syndromes , 1993, Circulation.

[15]  H. Katus,et al.  The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.

[16]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[17]  M. Nobuyoshi,et al.  Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.

[18]  R. Mulcahy,et al.  Unstable angina: natural history and determinants of prognosis. , 1981, The American journal of cardiology.

[19]  H Sandler,et al.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man. , 1968, American heart journal.

[20]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .

[21]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[22]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.